Drugs / (S)-propafenone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02710669 Comparator | Oct 2016 → Mar 2020 | atrial fibrillation | Vanderbilt University | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | (S)-propafenone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02710669 ↗ |
| Route | Intravenous | “Single intravenous dose of (S)-propafenone (2mg/kg) infused over 10 minutes” NCT02710669 ↗ |